Spencer Rascoff, who has served as a member of Match Group's board since March 2024, succeeds Bernard Kim, who's stepping ...

Cancer biotech Viracta Therapeutics has closed its doors, laying off all employees and winding down operations.

Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on ...

Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...

Sage Therapeutics rejects Biogen's $469M buyout offer. CEO Barry Greene and board seek alternatives, with Goldman Sachs ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Biogen Inc. is fending off a lawsuit in the Delaware Chancery Court over its recent offer to buy out Sage Therapeutics, its ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Tenax Therapeutics focuses on addressing cardiovascular and pulmonary diseases with high unmet medical needs. Besides levosimendan, the company may resume developing its oral formulation of imatinib.

Sage Therapeutics Inc. sued Biogen Inc. on Friday ... The court complaint followed a Jan. 10 public letter from Biogen CEO Chris Viehbacher—disclosing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TikTok CEO Shou Chew is expected to accept an invitation from President-elect Donald Trump to attend his inauguration. Chew will be seated front and center on the dais with other VIP guests and ...